Invitae Corp
NYSE:NVTA
Invitae Corp
Cash Equivalents
Invitae Corp
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Invitae Corp
NYSE:NVTA
|
Cash Equivalents
$158m
|
CAGR 3-Years
14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Cash Equivalents
$380.1m
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-9%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash Equivalents
$474m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
0%
|
CAGR 10-Years
13%
|
|
CVS Health Corp
NYSE:CVS
|
Cash Equivalents
$9.8B
|
CAGR 3-Years
21%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Cigna Corp
NYSE:CI
|
Cash Equivalents
$7.8B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
15%
|
CAGR 10-Years
11%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash Equivalents
$99.3m
|
CAGR 3-Years
-63%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-12%
|
See Also
What is Invitae Corp's Cash Equivalents?
Cash Equivalents
158m
USD
Based on the financial report for Sep 30, 2023, Invitae Corp's Cash Equivalents amounts to 158m USD.
What is Invitae Corp's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
9%
Over the last year, the Cash Equivalents growth was -27%. The average annual Cash Equivalents growth rates for Invitae Corp have been 14% over the past three years , 9% over the past five years .